Health ❯Medicine ❯Clinical Trials ❯Drug Approval

FDA

FDA Approves First New Schizophrenia Drug in Decades

Cobenfy, a novel treatment targeting acetylcholine receptors, offers hope for millions with schizophrenia.

FDA Approves Donanemab: A Breakthrough in Early Alzheimer’s Treatment

FDA Panel Recommends Approval of Promising Alzheimer's Drug Donanemab